Loading
Delineate
Delineate builds agentic systems for Model-Informed Drug Development. Its agents search PubMed and ClinicalTrials.gov, rank studies against custom criteria, and use computer vision to pull data from PK/PD plots, Kaplan-Meier curves and tables. It also offers a web-based modeling workstation with R, Python and Julia. It sells to pharma and biotech companies as a SaaS product. The company is Y Combinator Winter 2025 backed, and its BIO 2026 listing cites a $3.2M seed round and an active NIH grant. Investors listed on Crunchbase include Unpopular Ventures and Y Combinator.
Funding
Every round, secondary, debt facility or acquisition involving Delineate that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—